Electromicrograph of Influenza Viruses – Yi-ying Chou
Most Recent Peer-Reviewed Publication
Martínez-Guevara JL, Lai TY, Mishra M, Slamanig S, González-Domínguez I, Abdeljawad A, Hoang MT, Singh G, Kowdle S, Lee B, Krammer F, Palese P, Sun W. AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice. Vaccines (Basel). 2026;14(2):138. doi:10.3390/vaccines14020138. PMID:41746060
Simon V, Floda D, Gleason C, Gonzalez-Reiche AS, Paniz-Mondolfi AE, Sordillo EM, Palese P, van Bakel H. The pandemic gap of respiratory viruses during the COVID-19 pandemic. mBio. 2026;17(1):e0337625. doi:10.1128/mbio.03376-25. PMID:41369198
Boza M, Abdeljawad A, Slamanig S, Lemus N, Lai TY, Shea W, Sun W, Palese P, González-Domínguez I. Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines. Microbiol Spectr. 2026;14(1):e0065325. doi:10.1128/spectrum.00653-25. PMID:41288394
González-Domínguez I, Abdeljawad A, Lai TY, Boza M, McCroskery S, Lemus N, Slamanig S, Singh G, Warang P, Yellin T, Abbad A, Carreño JM, Dolange V, Martínez-Guevara JL, Singh G, Barcena-Varela M, Chang LA, Schotsaert M, Krammer F, Palese P, Sun W. Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models. Front Immunol. 2025;16:1524477. doi:10.3389/fimmu.2025.1524477. PMID:40165947
Dolange V, Slamanig S, Abdeljawad A, Lai TY, Lemus N, Singh G, Carreño JM, Abbad A, Srivastava K, Simon V, Sachithanandham J, Pekosz A, Sullivan D, Krammer F, Sun W, Palese P, González-Domínguez I. A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern. J Infect Dis. 2025;231(4):e723-e733. doi:10.1093/infdis/jiae645. PMID:39749487
Slamanig S, Lemus N, Lai TY, Singh G, Mishra M, Abdeljawad A, Boza M, Dolange V, Singh G, Lee B, González-Domínguez I, Schotsaert M, Krammer F, Palese P, Sun W. A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge. Vaccine. 2025;45:126586. doi:10.1016/j.vaccine.2024.126586. PMID:39667115
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines. J Virol. 2020 Jan 17;94(3):e01677-19. doi: 10.1128/JVI.01677-19. Print 2020 Jan 17.PMID: 31694938
González-Domínguez I, Puente-Massaguer E, Abdeljawad A, Lai TY, Liu Y, Loganathan M, Francis B, Lemus N, Dolange V, Boza M, Slamanig S, Martínez-Guevara JL, Krammer F, Palese P, Sun W. Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach. NPJ Vaccines. 2024;9(1):222. doi:10.1038/s41541-024-01014-8. PMID:39551795
Slamanig S, González-Domínguez I, Chang LA, Lemus N, Lai TY, Martínez JL, Singh G, Dolange V, Abdeljawad A, Kowdle S, Noureddine M, Warang P, Singh G, Lee B, García-Sastre A, Krammer F, Schotsaert M, Palese P, Sun W. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. EBioMedicine. 2024;105:105185. doi:10.1016/j.ebiom.2024.105185. PMID:38848648
Martínez JL, Lemus N, Lai TY, Mishra M, González-Domínguez I, Puente-Massaguer E, Loganathan M, Francis B, Samanovic MI, Krammer F, Mulligan MJ, Simon V, Palese P, Sun W. The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex. Vaccine. 2024;42(14):3365-3373. doi:10.1016/j.vaccine.2024.04.037. PMID:38627145